Basket cover image
16 handpicked stocks

Riding The Regulatory Wave In Healthcare

The Department of Justice's investigation into UnitedHealth's Medicare billing practices has cast a shadow over the health insurance industry, potentially leading to stricter oversight. This creates an investment opportunity in companies that provide compliance and auditing services, which are essential for navigating a more complex regulatory environment.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+6

Author avatar

Han Tan | Market Analyst

Updated 1 day ago | Published at July 25

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

UNH

UnitedHealth Group Incorporated

UNH

Current price

$304.01

HURN

HURON CONSULTING GROUP INC

HURN

Current price

$133.17

HCAT

Health Catalyst Inc

HCAT

Current price

$2.98

About This Group of Stocks

1

Our Expert Thinking

The Department of Justice investigation into UnitedHealth's Medicare billing practices signals a shift toward stricter oversight across the entire health insurance industry. This regulatory pressure creates opportunities for companies that provide essential compliance, auditing, and consulting services as healthcare organizations adapt to new standards.

2

What You Need to Know

This group includes both large healthcare insurers navigating regulatory challenges and specialized firms that provide compliance solutions. The theme is event-driven, focusing on companies positioned to benefit from increased demand for regulatory expertise and risk mitigation services in healthcare.

3

Why These Stocks

These stocks were handpicked by professional analysts based on their strategic positioning within the evolving regulatory landscape. The selection includes firms that either provide essential compliance services or are adapting successfully to heightened scrutiny, offering potential growth as the industry adjusts to new oversight standards.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+39.27%

Group Performance Snapshot

39.27%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 39.27% over the next year.

13 of 15

Stocks Rated Buy by Analysts

13 of 15 assets in this group are rated Buy by professional analysts.

953.3% vs 4%

Group Growth vs Bank interest

This group averaged a 953.3% return last month, beating the typical 4% bank rate.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

🔍

Regulatory Shift in Motion

The DOJ investigation into UnitedHealth signals a new era of healthcare oversight. Companies that help navigate compliance requirements could see increased demand as the industry adapts to stricter regulations.

📈

Growth Through Compliance

As healthcare organizations face heightened scrutiny, specialized consulting and auditing firms are positioned to benefit from the growing need for regulatory expertise and risk management services.

Event-Driven Opportunity

This curated selection targets companies strategically positioned around a specific regulatory catalyst. Professional analysts identified these stocks based on their potential to capitalize on industry-wide compliance challenges.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Uncle Sam's Semiconductor Stake

Uncle Sam's Semiconductor Stake

The U.S. government is considering an equity stake in Intel to boost domestic semiconductor manufacturing. This strategic move could create a ripple effect, benefiting other American companies involved in the chip-making industry.

View stocks
The Cybersecurity Consolidation Wave

The Cybersecurity Consolidation Wave

Accenture's record-breaking acquisition of CyberCX signals a major consolidation trend in the cybersecurity sector. This move highlights the growing demand for AI-powered security solutions, creating potential opportunities for other specialized cybersecurity firms to benefit from increased investment and M&A activity.

View stocks
American Chipmakers: A Tariff-Driven Shift

American Chipmakers: A Tariff-Driven Shift

President Trump has threatened to impose tariffs of up to 300% on semiconductors to boost domestic production. This creates a potential investment opportunity in U.S.-based semiconductor companies that stand to gain from a shift toward onshore manufacturing.

View stocks
View all Stock Groups

Frequently Asked Questions

Everything you need to know about the product and billing.